Baltic Export, Good for Business, Latvia, Markets and Companies, Medicine

International Internet Magazine. Baltic States news & analytics Tuesday, 09.06.2026, 08:04

Olainfarm sales at LVL 3.38 mln in May, growth 7%

BC, Riga, 18.06.2013.Print version
Provisional consolidated sales figures for the joint-stock pharmaceutical company Olainfarm reached LVL 3.38 million in May 2013, 7% more than a year ago, the company informed LETA/Nozare.lv.

The biggest increases were achieved in Kyrgyzstan (152%), Uzbekistan (111%) and Georgia (108%). The company's major sales markets were Russia, Latvia and Belarus.

 

In the first five months of 2013, Olainfarm provisional consolidated sales amounted to LVL 19.68 million, a 7% increase on the respective period in 2012.

 

The steepest increases in sales were achieved in the Netherlands (1,982%), Spain (233%) and Tajikistan (129%). Olainfarm major sales markets were Russia, Latvia, Belarus, Tajikistan and Kazakhstan.

 

The sales of pharmacies owned by Olainfarm constituted LVL 0,8 million in the first five months of 2013. The sales of pharmacies reached LVL 3.83 million.

 

According to Olainfarm provisional unconsolidated results, the company's sales were LVL 2.84 million in May. The steepest increases in sales were achieved in Kyrgyzstan (152%), Uzbekistan (111%) and Georgia (108%). The company's major sales markets were Russia, Latvia, Belarus and Tajikistan.

 

In the first five months of 2013, Olainfarm provisional unconsolidated sales amounted to LVL 16.85 million, a 6% increase on the corresponding period in 2012. The biggest sales increases were achieved in the Netherlands (1,982%), and Spain (233%). During this period, Olainfarm major sales markets were Russia, Latvia, Belarus, Ukraine and Kazakhstan.






Search site